| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥48.9B | ¥47.1B | +3.8% |
| Operating Income | ¥0.4B | ¥1.5B | -73.0% |
| Ordinary Income | ¥1.4B | ¥1.9B | -27.5% |
| Net Income | ¥0.7B | ¥0.9B | -19.6% |
| ROE | 5.2% | 6.9% | - |
FY2025 consolidated results show revenue of 48.9B yen (YoY +3.8%) with modest top-line growth, but profitability deteriorated significantly with operating income of 0.4B yen (YoY -73.0%), ordinary income of 1.4B yen (YoY -27.5%), and net income of 0.7B yen (YoY -19.6%). The company maintained revenue growth for consecutive periods but experienced a sharp profit decline, marking a critical inflection point in profitability trends. Operating margin compressed to 0.8% from 3.2% in the prior year, representing a deterioration of 2.4 percentage points, while net margin fell to 1.5% from 2.0%. The company transitioned from balanced revenue and profit growth to a revenue up/profit down pattern, primarily driven by segment-level deterioration in the Real Estate business and elevated depreciation expenses from aggressive capital investments.
Revenue increased 1.8B yen to 48.9B yen, driven entirely by the Nursing Care segment which grew 6.6B yen YoY to 48.2B yen, while the Real Estate segment contracted sharply from 5.5B yen to 0.6B yen in external sales. The Nursing Care business demonstrated stable demand for eldercare services, consistent with demographic tailwinds in Japan's aging society. However, the Real Estate segment experienced significant revenue volatility, likely reflecting project completion timing in construction contracting and real estate sales activities.
Operating income declined 1.1B yen to 0.4B yen due to three primary factors. First, gross profit margin compressed to 13.0% from prior levels as cost of sales increased 42.5B yen against revenue of 48.9B yen, suggesting pricing pressure or unfavorable business mix. Second, SG&A expenses remained elevated at 5.9B yen (12.2% of revenue), absorbing much of the gross profit. Third, depreciation expenses surged to 1.7B yen from 1.2B yen YoY (+40.2%), reflecting the impact of substantial capital investments in property, plant and equipment which increased 7.8B yen during the period. The Real Estate segment swung from operating profit of 0.4B yen to an operating loss of 0.4B yen, contributing negatively to consolidated profitability.
The gap between operating income (0.4B yen) and ordinary income (1.4B yen) of approximately 1.0B yen represents significant non-operating net income of 1.5B yen, partially offset by interest expense of 0.5B yen. Non-operating income comprised primarily non-specified items totaling 0.2B yen, while interest expense reflects the burden of increased borrowings. Interest expense represents 10.2% of operating income, indicating substantial financial leverage costs that constrain profitability. The effective tax rate of 40.9% on profit before tax further compressed net income to 0.7B yen.
This represents a revenue up/profit down pattern, where top-line growth could not offset operational inefficiencies, segment-level losses, elevated depreciation from capital intensity, and financial costs from debt-funded expansion.
The Nursing Care segment serves as the core business, generating 48.2B yen in revenue (98.7% of consolidated total) with operating income of 1.1B yen and an operating margin of 2.2%. Revenue grew 15.9% YoY from 41.6B yen, demonstrating consistent demand expansion in eldercare services. However, segment operating profit declined from 1.4B yen to 1.1B yen (-21.3% YoY), indicating margin compression despite volume growth, likely due to rising personnel costs and operational expenses inherent to labor-intensive care services.
The Real Estate segment generated 0.2B yen in revenue from external customers (0.6% of total) with additional intersegment revenue of 0.2B yen, totaling 0.2B yen in combined segment revenue. The segment recorded an operating loss of 0.4B yen, compared to operating profit of 0.4B yen in the prior year, representing a 0.8B yen deterioration. The operating margin of -16.6% reflects severe profitability challenges, likely attributable to project delivery timing, construction cost overruns, or impairment of real estate inventory. Segment assets increased from 3.2B yen to 3.8B yen (+17.4%), suggesting ongoing investment despite operational losses. The shift from profit to loss in Real Estate constitutes a material drag on consolidated operating income and warrants close monitoring of project pipeline recovery and asset utilization.
The margin differential between segments is substantial, with Nursing Care maintaining positive but compressed margins of 2.2% while Real Estate operates at negative margins. This divergence underscores concentration risk in the low-margin Nursing Care business and execution risk in the volatile Real Estate operations.
[Profitability] ROE of 5.2% declined from prior levels, reflecting compressed net margins and subdued return on equity despite elevated financial leverage. Operating margin of 0.8% represents a 2.4 percentage point deterioration from 3.2% YoY, indicating significant operational margin compression. Net profit margin of 1.5% declined from 2.0%, constrained by operating profit decline, interest expense of 0.5B yen, and an effective tax rate of 40.9%. Gross profit margin stood at 13.0%, suggesting limited pricing power or unfavorable cost structure in the company's service-oriented business model. [Cash Quality] Cash and deposits of 11.9B yen provide coverage of 0.9x against current liabilities of 13.9B yen, indicating tight liquidity positioning. Short-term debt coverage ratio stands at 2.6x when cash is measured against short-term borrowings of 4.5B yen, offering modest buffer. [Investment Efficiency] Total asset turnover of 0.84x reflects capital-intensive operations with substantial fixed asset base of 37.6B yen (64.7% of total assets). The company invested 9.8B yen in capital expenditures, representing 5.7x depreciation expense of 1.7B yen, indicating aggressive expansion phase. [Financial Health] Equity ratio of 24.3% remains below 30%, reflecting high leverage with total liabilities of 44.0B yen against equity of 14.1B yen. Current ratio of 139.7% provides adequate short-term liquidity coverage. Debt-to-equity ratio of 2.41x and interest-bearing debt of 34.1B yen (comprising long-term loans of 29.6B yen and short-term borrowings of 4.5B yen) indicate elevated financial leverage. Debt-to-EBITDA of 16.0x and interest coverage ratio of 0.84x raise concerns about debt service capacity, as operating income barely covers interest expense.
Operating cash flow of 2.9B yen represents 4.1x net income of 0.7B yen, indicating strong cash conversion from earnings and suggesting high-quality operating performance from a cash perspective despite weak profitability. Operating cash flow subtotal before working capital changes was 2.3B yen, with working capital providing modest inflows. Receivables increased 1.0B yen, reflecting revenue growth and potentially extended collection cycles, while payables increased 0.2B yen, indicating supplier credit utilization. Contract liabilities increased 0.4B yen, suggesting advance customer payments that support liquidity. Income taxes paid of 0.3B yen and interest paid of 0.5B yen represent cash outflows for tax obligations and financing costs. Investing cash flow of -10.1B yen was dominated by capital expenditures of 9.8B yen, reflecting substantial investment in property, plant and equipment to expand operational capacity, particularly in real estate and nursing care facilities. Free cash flow of -7.2B yen indicates that operating cash generation was insufficient to fund capital investments, necessitating external financing. Financing cash flow of 7.7B yen provided net inflows, primarily through long-term borrowing which increased 13.6B yen YoY to 29.6B yen, while short-term borrowings decreased 6.6B yen to 4.5B yen, suggesting refinancing from short-term to long-term debt to match investment duration and reduce rollover risk. The company's liquidity position improved with cash increasing from prior levels, but the reliance on debt financing to fund negative free cash flow raises sustainability concerns if capital investments fail to generate adequate returns.
Ordinary income of 1.4B yen versus operating income of 0.4B yen reflects a non-operating net contribution of approximately 1.0B yen, comprising non-operating income of 1.5B yen partially offset by non-operating expenses of 0.6B yen. Non-operating income represents 3.1% of revenue and consists primarily of other non-operating income of 0.2B yen with minimal interest and dividend income of less than 0.1B yen, suggesting the majority derives from non-specified items such as subsidy income or other ancillary gains referenced in qualitative disclosures. Interest expense of 0.5B yen constitutes the primary non-operating cost, reflecting financial leverage from interest-bearing debt of 34.1B yen. The material contribution of non-operating income to ordinary income raises concerns about core operating earnings sustainability, as ordinary income would compress significantly without these ancillary gains. Operating cash flow of 2.9B yen substantially exceeds net income of 0.7B yen, indicating healthy cash conversion and suggesting that accrual-based earnings are backed by cash generation. The absence of disclosed extraordinary items implies no material non-recurring gains or losses, though the Real Estate segment loss may contain project-specific elements. Overall earnings quality is constrained by weak operating profitability and dependence on non-operating income, though strong operating cash flow provides partial reassurance of cash-backed earnings.
The company forecasts full-year revenue of 59.5B yen (YoY +21.8%), operating income of 1.6B yen (YoY +300.6%), ordinary income of 2.0B yen (YoY +48.0%), and EPS of 81.13 yen. Current period performance represents the full-year result (FY2025), indicating the forecast pertains to the subsequent fiscal year (FY2026). The projected revenue growth of 21.8% implies significant expansion expectations, likely driven by nursing care facility additions and potential Real Estate segment recovery. Operating income is expected to quadruple from 0.4B yen to 1.6B yen, suggesting anticipated operational improvements including Real Estate segment turnaround from loss to profit and margin expansion in Nursing Care operations through operating leverage on revenue growth. The implied FY2026 operating margin of 2.7% would represent recovery toward prior year levels but remains modest. Ordinary income growth of 48.0% lags operating income growth, indicating continued interest expense burden from elevated debt levels. The forecast implies net income improvement assuming normalized tax rates. Key assumptions likely include Real Estate project pipeline normalization, nursing care capacity utilization improvement, and cost structure optimization to absorb depreciation increases. The aggressive growth forecast requires close monitoring of interim progress, particularly Real Estate segment profitability recovery and nursing care margin stabilization, as execution risks remain elevated given current segment performance.
The company paid no dividends for FY2025, with both interim and year-end dividends at zero yen. The dividend forecast for FY2026 also indicates zero yen, maintaining the no-dividend policy. Payout ratio is not applicable given zero dividend payments. The absence of dividends reflects capital allocation priorities focused on debt reduction, internal capital retention, and funding ongoing capital investments rather than shareholder distributions. With free cash flow of -7.2B yen and elevated debt levels (debt-to-equity of 2.41x), the company lacks sufficient cash generation to support dividend payments while maintaining financial stability. The continuation of zero dividends into FY2026 guidance suggests management prioritizes balance sheet repair and investment returns over near-term shareholder returns. Dividend resumption would require material improvement in free cash flow generation, debt reduction, and sustained profitability to ensure payout sustainability. No share buyback activity was disclosed.
First, Real Estate segment execution risk poses material downside, as the segment recorded an operating loss of 0.4B yen with -16.6% margin, contributing negatively to consolidated profitability. Project delays, construction cost inflation, or real estate market deterioration could prolong losses and impair asset values. Second, financial leverage risk is elevated with debt-to-equity of 2.41x, debt-to-EBITDA of 16.0x, and interest coverage of 0.84x, indicating operating income barely covers interest expense of 0.5B yen. Rising interest rates would materially increase financing costs and constrain profitability, while refinancing risk emerges if credit conditions tighten given weak debt service coverage. Third, operational margin compression in the core Nursing Care segment, where operating profit declined 21.3% despite 15.9% revenue growth, reflects structural profitability challenges from labor cost inflation, regulatory constraints, and limited pricing power. Sustained margin pressure could undermine earnings recovery even with revenue expansion.
[Industry Position] (Reference - Proprietary Analysis)
The company operates primarily in the nursing care services industry with ancillary real estate operations. Profitability metrics show material underperformance relative to sector norms. Operating margin of 0.8% compares unfavorably to typical nursing care operators maintaining 3-5% operating margins, indicating structural cost challenges or suboptimal facility utilization. ROE of 5.2% falls below industry median levels typically in the 7-10% range for established care service providers, reflecting compressed net margins and elevated leverage without commensurate returns. The equity ratio of 24.3% indicates higher financial leverage than industry median equity ratios typically above 30-35%, suggesting more aggressive capital structure and balance sheet risk. Debt-to-EBITDA of 16.0x substantially exceeds healthy industry benchmarks of 3-5x, placing the company in a high-risk category for debt sustainability and refinancing. Interest coverage of 0.84x critically underperforms industry standards above 2.0x, indicating inadequate operating earnings to service debt obligations. The company's revenue growth of 3.8% aligns with industry demographic trends supporting nursing care demand, but profitability conversion lags peers. The aggressive capital investment phase (CapEx of 9.8B yen, 5.7x depreciation) positions the company for capacity expansion but introduces near-term financial stress and execution risk. Overall, the company ranks in the lower quartile for profitability and financial health metrics within its industry, requiring operational turnaround and debt reduction to approach peer-level performance.
Profitability: ROE 5.2% (Industry positioning: below median, typical range 7-10%) Financial Health: Equity Ratio 24.3% (Industry positioning: below median, typical range 30-35%) Efficiency: Operating Margin 0.8% (Industry positioning: below median, typical range 3-5%) Leverage: Debt-to-EBITDA 16.0x (Industry positioning: high risk, typical range 3-5x)
※ Industry: Nursing Care Services, Comparison: Sector operators, Source: Proprietary analysis
First, the company exhibits a clear inflection point with operating margin deteriorating from 3.2% to 0.8% YoY, driven by Real Estate segment losses and Nursing Care margin compression despite revenue growth, indicating operational challenges that require structural correction rather than cyclical recovery. Second, aggressive capital investment of 9.8B yen (5.7x depreciation) funded by long-term debt which increased 85.3% to 29.6B yen has elevated financial leverage to critical levels with debt-to-EBITDA of 16.0x and interest coverage of 0.84x, constraining financial flexibility and creating vulnerability to interest rate increases or operational shortfalls. Third, the company's cash flow profile shows strong operating cash generation of 2.9B yen (4.1x net income) indicating cash-backed earnings quality, but negative free cash flow of -7.2B yen due to investment intensity necessitates continued reliance on external financing, making investment return realization critical to financial sustainability. Fourth, the zero dividend policy extending into FY2026 guidance reflects appropriate capital allocation given negative free cash flow and elevated leverage, prioritizing balance sheet repair over distributions. Fifth, the FY2026 forecast of revenue growth of 21.8% and operating income recovery to 1.6B yen (300.6% increase) implies ambitious operational turnaround assumptions requiring Real Estate segment return to profitability and Nursing Care margin improvement, with execution risk remaining high given current segment performance trends. Key monitoring priorities include Real Estate segment profitability trajectory, nursing care operating margin trends, debt reduction progress measured by debt-to-EBITDA normalization toward below 5x, and capital investment returns measured through ROIC improvement from current compressed levels.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.